Characteristics | Polypharmacy (≥ 5 drugs) n (%) | Major-polypharmacy (≥ 8 drugs) n (%) | ||||||
---|---|---|---|---|---|---|---|---|
MZ1 | P value | MZ2 | P value | MZ1 | P value | MZ2 | P value | |
Sex | 0.044 | 0.20 | 0.031 | 0.89 | ||||
Males | 461 (61.6) | 202 (53.9) | 204 (27.3) | 86 (22.9) | ||||
Females | 597 (66.4) | 267 (58.3) | 289 (32.3) | 103 (22.5) | ||||
Age group, years | < .001 | < .0001 | 0.004 | < .0001 | ||||
65–79 | 796 (62.0) | 329 (51.3) | 362 (28.2) | 119 (18.5) | ||||
≥ 80 | 262 (72.2) | 140 (73.3) | 131 (36.1) | 70 (36.7) | ||||
Education, years | 0.61 | < .001 | 0.38 | < .0001 | ||||
0–8 years | 359 (66.5) | 140 (68.0) | 170 (31.5) | 72 (35.0) | ||||
9–12 years | 333 (63.1) | 120 (52.2) | 163 (30.9) | 50 (21.7) | ||||
≥ 13 not academic | 155 (62.8) | 72 (57.1) | 72 (29.2) | 25 (19.8) | ||||
≥ 13 academic | 208 (63.4) | 121 (48.8) | 86 (26.2) | 39 (15.7) | ||||
Population group | 0.21 | 0.061 | 0.031 | 0.67 | ||||
Jews | 898 (64.9) | 410 (55.2) | 429 (31.0) | 167 (22.5) | ||||
Arabs | 160 (60.8) | 59 (65.6) | 64 (24.3) | 22 (24.4) | ||||
Socioeconomic status | 0.20 | 0.07 | 0.46 | 0.06 | ||||
Above poverty line | 597 (63.0) | 279 (53.0) | 273 (28.8) | 111 (21.1) | ||||
Below poverty line | 227 (67.0) | 77 (62.1) | 105 (31.0) | 36 (29.0) | ||||
Subjective Health status | < .0001 | < .0001 | < .0001 | < .0001 | ||||
Good | 459 (52.3) | 156 (40.7) | 167 (19.0) | 37 (9.7) | ||||
Poor | 599 (77.9) | 311 (69.9) | 326 (42.4) | 152 (34.2) | ||||
Comorbidity | < .0001 | < .0001 | < .0001 | < .0001 | ||||
No chronic illness | 51 (32.7) | 18 (18.6) | 13 (8.3) | 4 (4.1) | ||||
1–3 chronic illnesses | 785 (62.9) | 362 (57.0) | 340 (27.2) | 131 (20.6) | ||||
≥ 4 chronic illnesses | 217 (95.2) | 89 (89.0) | 137 (60.1) | 54 (54.0) |